Bristol-Myers Squibb | BMY - Pre Tax Profit


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

API Features Documentation Interested? Click here to contact us
Please Paste this Code in your Website
width
height
 Preview

Bristol-Myers Squibb

Bristol-Myers Squibb reported $5.12B in Pre-Tax Profit for its fiscal quarter ending in March of 2023.


Pre Tax Profit Change
AbbVie ABBV:US USD 5.08B 2.33B
Abbott ABT:US USD 2.11B 61M
AstraZeneca AZN:LN USD 3.71B 1.41B
Catalent CTLT:US USD 167M 111M
Coherus Biosciences CHRS:US USD -75729000 16.86M
Intercept Pharmaceuticals ICPT:US USD -31881000 14.34M
J&J JNJ:US USD 8.47B 1.05B
Merck & Co MRK:US USD 4.48B 411M
Prestige Brands PBH:US USD -299522000 367.64M
Revance Therapeutics RVNC:US USD -59793000 86.16M
Roche Holding ROG:VX CHF 8.85B 3.26B
United Therapeutics UTHR:US USD 291.9M 113.1M